Company

MIMARK Diagnostics S.L.

MIMARK Diagnostics develops in vitro tests to support the diagnosis and management of gynecological cancers.

About

Founded in 2021 and based in Barcelona, MIMARK Diagnostics develops in vitro diagnostic solutions for gynecological cancers, including endometrial cancer. Its WomEC test analyzes proteins in a uterine aspirate sample. In June 2023, the company raised EUR 1 million from Clave Capital, Nara Capital, Namarel Ventures, and Women Angels for STEAM to advance its cancer diagnostic tests.

2Funding rounds

4Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in